No Improvement of progression free Survival of Patients with locally advanced NSCLC through consolidation Chemotherapy after concurrent Chemoradiation

Ebert Nadja; Baumann Michael

首页> 外文期刊>Strahlentherapie und Onkologie >No Improvement of progression free Survival of Patients with locally advanced NSCLC through consolidation Chemotherapy after concurrent Chemoradiation

【24h】

No Improvement of progression free Survival of Patients with locally advanced NSCLC through consolidation Chemotherapy after concurrent Chemoradiation

机译：同期放化疗后通过巩固化疗治疗局部晚期NSCLC患者的无进展生存期无改善

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Strahlentherapie und Onkologie》 |2016年第2期|共3页
作者
Ebert Nadja; Baumann Michael;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 ger
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. No Improvement of progression free Survival of Patients with locally advanced NSCLC through consolidation Chemotherapy after concurrent Chemoradiation [J] . Ebert Nadja, Baumann Michael Strahlentherapie und Onkologie . 2016,第2期

机译：同期放化疗后通过巩固化疗治疗局部晚期NSCLC患者的无进展生存期无改善
2. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management [J] . J. Joshua Smith, Oliver S. Chow, Marc J. Gollub, BMC Cancer . 2015,第1期

机译：直肠腺癌的器官保存：一项II期随机对照试验，评估了局部晚期直肠癌患者的3年无病生存率，这些患者接受化学放疗，诱导或巩固化疗以及全直肠系膜切除或非手术治疗
3. 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45Gy (1.5Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-A multicenter phase-II trial (CISTAXOL) [J] . EberhardtW.E.E., GaulerT.C., LePechouxC., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2013,第1期

机译：局部晚期晚期非小细胞肺癌（NSCLC）-A的三周期顺铂/紫杉醇联合顺铂/依托泊苷/ 45Gy（1.5Gy bid）放化疗同时进行手术的诱导化疗的10年长期生存（LTS）多中心II期试验（CISTAXOL）
4. Functional outcome after concurrent chemoradiation in patients with locally advanced laryngeal or hypopharyngeal cancer [C] . Furukawa Madoka K., Kubota A., Yagi H., World Congress for Bronchology and Interventional Pulmonology . 2013

机译：在局部晚期喉部或白阴癌患者的同时趋化后的功能结果
5. Association of patient-reported outcomes with progression-free survival in malignant pleural mesothelioma. [D] . Hackshaw, Michelle Denise. 2010

机译：患者报告的结局与恶性胸膜间皮瘤无进展生存的相关性。
6. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy and total mesorectal excision or nonoperative management [O] . J. Joshua Smith, Oliver S. Chow, Marc J. Gollub, 2015

机译：直肠腺癌的器官保存：一项II期随机对照试验评估在局部晚期直肠癌患者中进行化学放疗诱导或巩固化疗以及全直肠系膜切除或非手术治疗的3年无病生存率
7. A Phase II Study of Concurrent Chemoradiation with Weekly Docetaxel, Carboplatin, and Radiation Therapy Followed by Consolidation Chemotherapy with Docetaxel and Carboplatin for Locally Advanced Inoperable Non-small Cell Lung Cancer (NSCLC) [O] . Jain Anshu K., Hughes Randall S., Sandler Alan B., 2009

机译：每周多西他赛，卡铂联合放疗和放疗联合多西他赛和卡铂联合化疗治疗局部晚期不可手术的非小细胞肺癌（NSCLC）的II期研究

No Improvement of progression free Survival of Patients with locally advanced NSCLC through consolidation Chemotherapy after concurrent Chemoradiation

著录项

相似文献

相关主题

期刊订阅